1. Home
  2. HRB vs CRSP Comparison

HRB vs CRSP Comparison

Compare HRB & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$37.19

Market Cap

4.9B

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$54.91

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
CRSP
Founded
1955
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.9B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
HRB
CRSP
Price
$37.19
$54.91
Analyst Decision
Sell
Buy
Analyst Count
2
17
Target Price
$41.00
$70.29
AVG Volume (30 Days)
2.1M
1.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
5.34%
N/A
EPS Growth
6.55
N/A
EPS
3.38
N/A
Revenue
$3,159,931,000.00
$289,590,000.00
Revenue This Year
$4.39
$807.72
Revenue Next Year
$3.21
$172.52
P/E Ratio
$10.59
N/A
Revenue Growth
N/A
9169.85
52 Week Low
$28.16
$44.12
52 Week High
$56.76
$78.48

Technical Indicators

Market Signals
Indicator
HRB
CRSP
Relative Strength Index (RSI) 53.44 53.13
Support Level $29.24 $50.17
Resistance Level $39.96 $60.10
Average True Range (ATR) 1.16 2.57
MACD -0.17 0.19
Stochastic Oscillator 66.77 60.16

Price Performance

Historical Comparison
HRB
CRSP

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: